Elanco Animal Health
June 24, 2026
Theater 1
Type: Company Presentation
Focus Area:
Multiple Therapeutics
Elanco is a US based veterinary pharmaceutical company, developing products for both Pet Health and Livestock applications, including therapeutics for chronic disease, anti-microbials, and vaccines.
Company HQ City:
Indianapolis
Company HQ State:
Indiana
Company HQ Country:
United States
Year Founded:
1954
Lead Product in Development:
Multiple Assets involved in canine and feline inflammation, chronic pain, and infectious disease, and multiple assets in farm animal infectious disease prevention, performance, and sustainability
CEO
Jeffrey Simmons
Development Phase of Lead Product
Multiple Products in Market
Exchange
NYSE
Ticker
ELAN
When you expect your next catalyst update?
May 2026
What is your next catalyst (value inflection) update?
Elanco provides quarterly earnings reports
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}